Literature DB >> 5220246

Ethambutol: a substitute for para-aminosalicylic acid in regimens for pulmonary tuberculosis.

S H Ferebee, B E Doster, F J Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5220246     DOI： 10.1111/j.1749-6632.1966.tb45533.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Authors:  Yusuke Minato; Joshua M Thiede; Shannon Lynn Kordus; Edward J McKlveen; Breanna J Turman; Anthony D Baughn
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

3.  Modern management of tuberculosis.

Authors:  R C Young; A C Lindo; R L Hackney
Journal:  J Natl Med Assoc       Date:  1969-05       Impact factor: 1.798

4.  [Results of daily-oral therapy with ethambutol and isoniazid in tuberculosis (author's transl)].

Authors:  H K Schwabe; A Heymer; A Wahlen; M Stollenwerk
Journal:  Pneumonologie       Date:  1973-09-28

5.  The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria.

Authors:  Karin Schubert; Boris Sieger; Fabian Meyer; Giacomo Giacomelli; Kati Böhm; Angela Rieblinger; Laura Lindenthal; Nadja Sachs; Gerhard Wanner; Marc Bramkamp
Journal:  mBio       Date:  2017-02-07       Impact factor: 7.867
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.